Wells Fargo lowered the firm’s price target on Enovis (ENOV) to $59 from $62 and keeps an Overweight rating on the shares. The firm notes Q4 EPS and revenues were ahead of the Street and 2025 guidance largely brackets consensus. Wells expects management to continue executing over 2025, delivering above-market Recon growth.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ENOV:
- Enovis’s Strong Financial Performance and Strategic Positioning Earns Buy Rating
- Enovis Corporation Faces Financial Strain Amid U.S.-China Tariff Uncertainty
- Enovis Corporation Reports Strong Sales Growth Amid Challenges
- Enovis Positioned for Growth: Buy Rating Backed by Strong Sales, Product Launches, and Attractive Valuation
- Enovis: Strong Financial Performance and Growth Potential Justify Buy Rating